Clarassance, Inc.
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Safety, Pk and Anti-inflammatory Effects of CC10 Protein in Premature Infants With Respiratory Distress Syndrome (RDS) (NCT01473264) | Clarassance, Inc. | 2000-01-01 |
Track Clarassance, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.